Price $26.84 |
Market Cap
37.04B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
47.3
|
P/B
5.11
|
P/S
4.25
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
12.40%
|
Net Margin
9.00%
|
ROE
11.50%
|
ROI
5.10%
|
|
ROA
4.40%
|
EPS Growth
325.80%
|
Current Ratio
0.9
|
Debt/Equity
80.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aytu Bioscience Inc (AYTU) | $0.23 | - | - | 6.7M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $1.11 | - | - | 81.6M | Strong Buy |
| Perrigo Company PLC (PRGO) | $77.42 | - | 0.90% | 10.6B | Strong Buy |
| CV Sciences Inc (CVSI) | $0.24 | - | - | 22.8M | Strong Buy |
| Encision Inc (ECIA) | $0.42 | - | - | 4.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
